Global Digestive Enzymes Market Size

Digestive Enzymes Market Analysis

The digestive enzymes market is expected to register a CAGR of 8.3% over the forecast period-2022-2027.  

The novel coronavirus has significantly impacted all industries, including food and beverage, automotive, chemicals, and many others. This pandemic has resulted in mass production shutdowns and supply chain disruptions, which have affected the global economy. Thus, such factors adversely affected the market initially. However, increasing gastrointestinal symptoms among patients who have suffered from COVID-19 positively impacted the market in later times. According to the study titled, "Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome" published in December 2020, COVID-19 patients experienced gastrointestinal symptoms such as anorexia (17.9%), nausea (17.9%), and diarrhea (24.2%). It also reported that in patients who suffered severely from COVID-19, the symptoms of gastrointestinal disorders became more pronounced. Digestive enzymes help to break food substances for easy digestion. These proteins speed up chemical reactions that turn nutrients into substances so that the digestive tract can absorb. Thus, digestive enzymes are one of the essential element for treating gastrointestinal disorders. Therefore, such instances indicate that the market witnessed a positive impact during later times of the pandemic.

Factors such as the rising geriatric population, the rising prevalence of gastrointestinal disorders, increasing awareness about GI health, and focus on preventive health management are contributing to the market growth. The global population is aging rapidly, owing to reduced birth rates and rising life expectancy. The demographic trend toward an elderly population represents a rising need for the management of disorders, such as GI tract obstructions. According to the report published by the World Health Organisation in October 2021, the proportion of the population aged 60 and over will increase from 1 billion in 2020 to 1.4 billion in 2030. It also reported that by 2050, the world's population of people aged 60 and over will double around 2.1 billion. The secretion of digestive enzymes usually reduces with age that contributes to high levels of gastric discomfort, lower digestion rates, reduced food consumption, and/or a variety of other GI disorders. Therefore, with the rising elderly population, the market for digestive enzymes is expected to grow over the forecast period.

However, perception of probiotic and prebiotic products as alternatives to digestive enzymes and stringent regulatory policies are likely to hinder the market growth over the forecast period.